Luka Stonkic (@lukastonkic77) 's Twitter Profile
Luka Stonkic

@lukastonkic77

Mavs and Money. Tweets are just opinions, not advice.

ID: 1434145936381448193

calendar_today04-09-2021 13:27:10

792 Tweet

129 Takipçi

91 Takip Edilen

Luka Stonkic (@lukastonkic77) 's Twitter Profile Photo

$UNH bought a ton of shares today and some August $400c Will be a matter of time before people realize the CEO stepping down is a good thing for the stock.

Luka Stonkic (@lukastonkic77) 's Twitter Profile Photo

Bought the bottom on these. Trimmed about 60% today as I think we are getting over extended. $hood $coin $tsla $amd $nvda. Will be watching for a pullback to add back more.

Luka Stonkic (@lukastonkic77) 's Twitter Profile Photo

$UNH top watch into next week. Chart is primed. Bold prediction - UNH announces buybacks and says they dont feel there is anything to the fraud situation. Whether true or not, I think we hit 350 next week

Actuate Therapeutics (@actuatethera) 's Twitter Profile Photo

Actuate today presented topline results from the Phase 2 (Actuate-1801 Part 3B) trial of elraglusib in combination with GnP in previously untreated patients with metastatic pancreatic ductal adenocarcinoma at the ASCO Annual Meeting. Details: bit.ly/4jvm95c $ACTU

Actuate Therapeutics (@actuatethera) 's Twitter Profile Photo

"The addition of elraglusib to the existing chemotherapy backbone of gemcitabine and nab-paclitaxel is promising and may represent a meaningful therapeutic advance for patients with pancreatic cancer.” - Dr. Mahalingam, MD, PhD. Read more: bit.ly/4jvm95c $ACTU #ASCO25

The North Star (@thenorthstar5) 's Twitter Profile Photo

$ACTU Listen to the KOL event.  Notable quotes: "I'll give it to all my patients, I'm all in" --Colin "I would give ELRA to ALL my patients due to the data" --Deva "Here we are not seeing that toxicity. This is a go!" --Toni

Luka Stonkic (@lukastonkic77) 's Twitter Profile Photo

$actu this is a big deal. Price action will follow. Mostly unnoticed stock up to this point, but this news should make some waves. Also low float. Holding until $30 at least fiercebiotech.com/biotech/asco-a…

Luka Stonkic (@lukastonkic77) 's Twitter Profile Photo

I dot really care If $HOOD is included today or in two years. Holding for a decade. If they’re left out, a few will get shaken out as we go fill the gap around $68, before heading to 80+. Will buy more there